APO Research
Talk to an analyst

APO RESEARCH · REPORT

Verapamil Hydrochloride Injection

Compare research editions
View pricing & licenses

Selected research

Industry Research

Verapamil Hydrochloride Injection Industry Research Report 2026

20 December 2025131 pages

Choose your research edition.

Industry ResearchVerapamil Hydrochloride Injection Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Verapamil Hydrochloride Injection Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Verapamil Hydrochloride Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Verapamil Hydrochloride Injection Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Verapamil Hydrochloride Injection Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Verapamil Hydrochloride Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Verapamil Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Verapamil Hydrochloride Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Verapamil Hydrochloride Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Verapamil Hydrochloride Injection include ACIC Pharmaceuticals, Exela Pharma, Gland Pharma, Mankind Pharma, Duoduo Pharmaceutical, Harbin Pharm. Group Sanjing Pharmaceutical, Hubei Weishi, China Res Double-Crane and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Verapamil Hydrochloride Injection market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Verapamil Hydrochloride Injection Market by Company

ACIC Pharmaceuticals

Exela Pharma

Gland Pharma

Mankind Pharma

Duoduo Pharmaceutical

Harbin Pharm. Group Sanjing Pharmaceutical

Hubei Weishi

China Res Double-Crane

Pfizer

Jilin Jinsheng Pharmaceutical

Jiangsu Langou Drug

Jiangsu Ruinian Qianjin Pharmacy

Zydus Pharmaceuticals

Shanghai Harvest Pharmaceutical

Shiyao YINHU Pharmaceutical

Chia Tai-Tianqing Pharmaceutical

Chongqing Yaoyou Pharmacy

Verapamil Hydrochloride Injection Segment by Type

Oral

Intravenous Injection

Verapamil Hydrochloride Injection Segment by Application

Hospital

Clinics

Other

Verapamil Hydrochloride Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Verapamil Hydrochloride Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Verapamil Hydrochloride Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Verapamil Hydrochloride Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Verapamil Hydrochloride Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Verapamil Hydrochloride Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Verapamil Hydrochloride Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Verapamil Hydrochloride Injection Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Verapamil Hydrochloride Injection Sales (k units) of Manufacturers (2021-2026) Table 7. Global Verapamil Hydrochloride Injection Sales Market Share by Manufacturers (2021-2026) Table 8. Global Verapamil Hydrochloride Injection Revenue of Manufacturers (2021-2026) Table 9. Global Verapamil Hydrochloride Injection Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Verapamil Hydrochloride Injection Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Verapamil Hydrochloride Injection Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Verapamil Hydrochloride Injection, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Verapamil Hydrochloride Injection, Product Type & Application Table 14. Global Verapamil Hydrochloride Injection Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Verapamil Hydrochloride Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. ACIC Pharmaceuticals Company Information Table 19. ACIC Pharmaceuticals Business Overview Table 20. ACIC Pharmaceuticals Verapamil Hydrochloride Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. ACIC Pharmaceuticals Verapamil Hydrochloride Injection Product Portfolio Table 22. ACIC Pharmaceuticals Recent Developments Table 23. Exela Pharma Company Information Table 24. Exela Pharma Business Overview Table 25. Exela Pharma Verapamil Hydrochloride Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Exela Pharma Verapamil Hydrochloride Injection Product Portfolio Table 27. Exela Pharma Recent Developments Table 28. Gland Pharma Company Information Table 29. Gland Pharma Business Overview Table 30. Gland Pharma Verapamil Hydrochloride Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Gland Pharma Verapamil Hydrochloride Injection Product Portfolio Table 32. Gland Pharma Recent Developments Table 33. Mankind Pharma Company Information Table 34. Mankind Pharma Business Overview Table 35. Mankind Pharma Verapamil Hydrochloride Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Mankind Pharma Verapamil Hydrochloride Injection Product Portfolio Table 37. Mankind Pharma Recent Developments Table 38. Duoduo Pharmaceutical Company Information Table 39. Duoduo Pharmaceutical Business Overview Table 40. Duoduo Pharmaceutical Verapamil Hydrochloride Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Duoduo Pharmaceutical Verapamil Hydrochloride Injection Product Portfolio Table 42. Duoduo Pharmaceutical Recent Developments Table 43. Harbin Pharm. Group Sanjing Pharmaceutical Company Information Table 44. Harbin Pharm. Group Sanjing Pharmaceutical Business Overview Table 45. Harbin Pharm. Group Sanjing Pharmaceutical Verapamil Hydrochloride Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Harbin Pharm. Group Sanjing Pharmaceutical Verapamil Hydrochloride Injection Product Portfolio Table 47. Harbin Pharm. Group Sanjing Pharmaceutical Recent Developments Table 48. Hubei Weishi Company Information Table 49. Hubei Weishi Business Overview Table 50. Hubei Weishi Verapamil Hydrochloride Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Hubei Weishi Verapamil Hydrochloride Injection Product Portfolio Table 52. Hubei Weishi Recent Developments Table 53. China Res Double-Crane Company Information Table 54. China Res Double-Crane Business Overview Table 55. China Res Double-Crane Verapamil Hydrochloride Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. China Res Double-Crane Verapamil Hydrochloride Injection Product Portfolio Table 57. China Res Double-Crane Recent Developments Table 58. Pfizer Company Information Table 59. Pfizer Business Overview Table 60. Pfizer Verapamil Hydrochloride Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Pfizer Verapamil Hydrochloride Injection Product Portfolio Table 62. Pfizer Recent Developments Table 63. Jilin Jinsheng Pharmaceutical Company Information Table 64. Jilin Jinsheng Pharmaceutical Business Overview Table 65. Jilin Jinsheng Pharmaceutical Verapamil Hydrochloride Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Jilin Jinsheng Pharmaceutical Verapamil Hydrochloride Injection Product Portfolio Table 67. Jilin Jinsheng Pharmaceutical Recent Developments Table 68. Jiangsu Langou Drug Company Information Table 69. Jiangsu Langou Drug Business Overview Table 70. Jiangsu Langou Drug Verapamil Hydrochloride Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Jiangsu Langou Drug Verapamil Hydrochloride Injection Product Portfolio Table 72. Jiangsu Langou Drug Recent Developments Table 73. Jiangsu Ruinian Qianjin Pharmacy Company Information Table 74. Jiangsu Ruinian Qianjin Pharmacy Business Overview Table 75. Jiangsu Ruinian Qianjin Pharmacy Verapamil Hydrochloride Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Jiangsu Ruinian Qianjin Pharmacy Verapamil Hydrochloride Injection Product Portfolio Table 77. Jiangsu Ruinian Qianjin Pharmacy Recent Developments Table 78. Zydus Pharmaceuticals Company Information Table 79. Zydus Pharmaceuticals Business Overview Table 80. Zydus Pharmaceuticals Verapamil Hydrochloride Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Zydus Pharmaceuticals Verapamil Hydrochloride Injection Product Portfolio Table 82. Zydus Pharmaceuticals Recent Developments Table 83. Shanghai Harvest Pharmaceutical Company Information Table 84. Shanghai Harvest Pharmaceutical Business Overview Table 85. Shanghai Harvest Pharmaceutical Verapamil Hydrochloride Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Shanghai Harvest Pharmaceutical Verapamil Hydrochloride Injection Product Portfolio Table 87. Shanghai Harvest Pharmaceutical Recent Developments Table 88. Shiyao YINHU Pharmaceutical Company Information Table 89. Shiyao YINHU Pharmaceutical Business Overview Table 90. Shiyao YINHU Pharmaceutical Verapamil Hydrochloride Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Shiyao YINHU Pharmaceutical Verapamil Hydrochloride Injection Product Portfolio Table 92. Shiyao YINHU Pharmaceutical Recent Developments Table 93. Chia Tai-Tianqing Pharmaceutical Company Information Table 94. Chia Tai-Tianqing Pharmaceutical Business Overview Table 95. Chia Tai-Tianqing Pharmaceutical Verapamil Hydrochloride Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Chia Tai-Tianqing Pharmaceutical Verapamil Hydrochloride Injection Product Portfolio Table 97. Chia Tai-Tianqing Pharmaceutical Recent Developments Table 98. Chongqing Yaoyou Pharmacy Company Information Table 99. Chongqing Yaoyou Pharmacy Business Overview Table 100. Chongqing Yaoyou Pharmacy Verapamil Hydrochloride Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Chongqing Yaoyou Pharmacy Verapamil Hydrochloride Injection Product Portfolio Table 102. Chongqing Yaoyou Pharmacy Recent Developments Table 103. Global Verapamil Hydrochloride Injection Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 104. Global Verapamil Hydrochloride Injection Sales by Region (2021-2026) & (k units) Table 105. Global Verapamil Hydrochloride Injection Sales Market Share by Region (2021-2026) Table 106. Global Verapamil Hydrochloride Injection Sales by Region (2027-2032) & (k units) Table 107. Global Verapamil Hydrochloride Injection Sales Market Share by Region (2027-2032) Table 108. Global Verapamil Hydrochloride Injection Revenue by Region (2021-2026) & (US$ Million) Table 109. Global Verapamil Hydrochloride Injection Revenue Market Share by Region (2021-2026) Table 110. Global Verapamil Hydrochloride Injection Revenue by Region (2027-2032) & (US$ Million) Table 111. Global Verapamil Hydrochloride Injection Revenue Market Share by Region (2027-2032) Table 112. North America Verapamil Hydrochloride Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. North America Verapamil Hydrochloride Injection Sales by Country (2021-2026) & (k units) Table 114. North America Verapamil Hydrochloride Injection Sales by Country (2027-2032) & (k units) Table 115. North America Verapamil Hydrochloride Injection Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Verapamil Hydrochloride Injection Revenue by Country (2027-2032) & (US$ Million) Table 117. Europe Verapamil Hydrochloride Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Europe Verapamil Hydrochloride Injection Sales by Country (2021-2026) & (k units) Table 119. Europe Verapamil Hydrochloride Injection Sales by Country (2027-2032) & (k units) Table 120. Europe Verapamil Hydrochloride Injection Revenue by Country (2021-2026) & (US$ Million) Table 121. Europe Verapamil Hydrochloride Injection Revenue by Country (2027-2032) & (US$ Million) Table 122. Asia Pacific Verapamil Hydrochloride Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Asia Pacific Verapamil Hydrochloride Injection Sales by Country (2021-2026) & (k units) Table 124. Asia Pacific Verapamil Hydrochloride Injection Sales by Country (2027-2032) & (k units) Table 125. Asia Pacific Verapamil Hydrochloride Injection Revenue by Country (2021-2026) & (US$ Million) Table 126. Asia Pacific Verapamil Hydrochloride Injection Revenue by Country (2027-2032) & (US$ Million) Table 127. South America Verapamil Hydrochloride Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. South America Verapamil Hydrochloride Injection Sales by Country (2021-2026) & (k units) Table 129. South America Verapamil Hydrochloride Injection Sales by Country (2027-2032) & (k units) Table 130. South America Verapamil Hydrochloride Injection Revenue by Country (2021-2026) & (US$ Million) Table 131. South America Verapamil Hydrochloride Injection Revenue by Country (2027-2032) & (US$ Million) Table 132. Middle East and Africa Verapamil Hydrochloride Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Middle East and Africa Verapamil Hydrochloride Injection Sales by Country (2021-2026) & (k units) Table 134. Middle East and Africa Verapamil Hydrochloride Injection Sales by Country (2027-2032) & (k units) Table 135. Middle East and Africa Verapamil Hydrochloride Injection Revenue by Country (2021-2026) & (US$ Million) Table 136. Middle East and Africa Verapamil Hydrochloride Injection Revenue by Country (2027-2032) & (US$ Million) Table 137. Global Verapamil Hydrochloride Injection Sales by Type (2021-2026) & (k units) Table 138. Global Verapamil Hydrochloride Injection Sales by Type (2027-2032) & (k units) Table 139. Global Verapamil Hydrochloride Injection Sales Market Share by Type (2021-2026) Table 140. Global Verapamil Hydrochloride Injection Sales Market Share by Type (2027-2032) Table 141. Global Verapamil Hydrochloride Injection Revenue by Type (2021-2026) & (US$ Million) Table 142. Global Verapamil Hydrochloride Injection Revenue by Type (2027-2032) & (US$ Million) Table 143. Global Verapamil Hydrochloride Injection Revenue Market Share by Type (2021-2026) Table 144. Global Verapamil Hydrochloride Injection Revenue Market Share by Type (2027-2032) Table 145. Global Verapamil Hydrochloride Injection Price by Type (2021-2026) & (US$/unit) Table 146. Global Verapamil Hydrochloride Injection Price by Type (2027-2032) & (US$/unit) Table 147. Global Verapamil Hydrochloride Injection Sales by Application (2021-2026) & (k units) Table 148. Global Verapamil Hydrochloride Injection Sales by Application (2027-2032) & (k units) Table 149. Global Verapamil Hydrochloride Injection Sales Market Share by Application (2021-2026) Table 150. Global Verapamil Hydrochloride Injection Sales Market Share by Application (2027-2032) Table 151. Global Verapamil Hydrochloride Injection Revenue by Application (2021-2026) & (US$ Million) Table 152. Global Verapamil Hydrochloride Injection Revenue by Application (2027-2032) & (US$ Million) Table 153. Global Verapamil Hydrochloride Injection Revenue Market Share by Application (2021-2026) Table 154. Global Verapamil Hydrochloride Injection Revenue Market Share by Application (2027-2032) Table 155. Global Verapamil Hydrochloride Injection Price by Application (2021-2026) & (US$/unit) Table 156. Global Verapamil Hydrochloride Injection Price by Application (2027-2032) & (US$/unit) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Verapamil Hydrochloride Injection Distributors List Table 160. Verapamil Hydrochloride Injection Customers List Table 161. Verapamil Hydrochloride Injection Industry Trends Table 162. Verapamil Hydrochloride Injection Industry Drivers Table 163. Verapamil Hydrochloride Injection Industry Restraints Table 164. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Verapamil Hydrochloride Injection Product Image Figure 5. Global Verapamil Hydrochloride Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Verapamil Hydrochloride Injection Market Size (2021-2032) & (US$ Million) Figure 7. Global Verapamil Hydrochloride Injection Sales (2021-2032) & (k units) Figure 8. Global Verapamil Hydrochloride Injection Average Price (US$/unit) & (2021-2032) Figure 9. Oral Product Image Figure 10. Intravenous Injection Product Image Figure 11. Hospital Product Image Figure 12. Clinics Product Image Figure 13. Other Product Image Figure 14. Global Verapamil Hydrochloride Injection Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Verapamil Hydrochloride Injection, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Verapamil Hydrochloride Injection Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Verapamil Hydrochloride Injection Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Verapamil Hydrochloride Injection Sales by Region in 2025 Figure 20. Global Verapamil Hydrochloride Injection Revenue by Region in 2025 Figure 21. North America Verapamil Hydrochloride Injection Market Size by Country in 2025 Figure 22. North America Verapamil Hydrochloride Injection Sales Market Share by Country (2021-2032) Figure 23. North America Verapamil Hydrochloride Injection Revenue Market Share by Country (2021-2032) Figure 24. United States Verapamil Hydrochloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Verapamil Hydrochloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Verapamil Hydrochloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Verapamil Hydrochloride Injection Market Size by Country in 2025 Figure 28. Europe Verapamil Hydrochloride Injection Sales Market Share by Country (2021-2032) Figure 29. Europe Verapamil Hydrochloride Injection Revenue Market Share by Country (2021-2032) Figure 30. Germany Verapamil Hydrochloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Verapamil Hydrochloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Verapamil Hydrochloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Verapamil Hydrochloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Verapamil Hydrochloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Verapamil Hydrochloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Verapamil Hydrochloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Verapamil Hydrochloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Verapamil Hydrochloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Verapamil Hydrochloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Verapamil Hydrochloride Injection Market Size by Country in 2025 Figure 41. Asia Pacific Verapamil Hydrochloride Injection Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Verapamil Hydrochloride Injection Revenue Market Share by Country (2021-2032) Figure 43. China Verapamil Hydrochloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Verapamil Hydrochloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Verapamil Hydrochloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Verapamil Hydrochloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Verapamil Hydrochloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Verapamil Hydrochloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Verapamil Hydrochloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Verapamil Hydrochloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Verapamil Hydrochloride Injection Market Size by Country in 2025 Figure 52. South America Verapamil Hydrochloride Injection Sales Market Share by Country (2021-2032) Figure 53. South America Verapamil Hydrochloride Injection Revenue Market Share by Country (2021-2032) Figure 54. Brazil Verapamil Hydrochloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Verapamil Hydrochloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Verapamil Hydrochloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Verapamil Hydrochloride Injection Market Size by Country in 2025 Figure 58. Middle East and Africa Verapamil Hydrochloride Injection Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Verapamil Hydrochloride Injection Revenue Market Share by Country (2021-2032) Figure 60. Egypt Verapamil Hydrochloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Verapamil Hydrochloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Verapamil Hydrochloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Verapamil Hydrochloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Verapamil Hydrochloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Verapamil Hydrochloride Injection Sales Market Share by Type (2021-2032) Figure 66. Global Verapamil Hydrochloride Injection Revenue Market Share by Type (2021-2032) Figure 67. Global Verapamil Hydrochloride Injection Price (US$/unit) by Type (2021-2032) Figure 68. Global Verapamil Hydrochloride Injection Sales Market Share by Application (2021-2032) Figure 69. Global Verapamil Hydrochloride Injection Revenue Market Share by Application (2021-2032) Figure 70. Global Verapamil Hydrochloride Injection Price (US$/unit) by Application (2021-2032) Figure 71. Verapamil Hydrochloride Injection Value Chain Figure 72. Verapamil Hydrochloride Injection Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Verapamil Hydrochloride Injection Industry Opportunities and Challenges

Scope & coverage.

Types
  • Oral
  • Intravenous Injection
Applications
  • Hospital
  • Clinics
  • Other
Companies covered
  • ACIC Pharmaceuticals
  • Exela Pharma
  • Gland Pharma
  • Mankind Pharma
  • Duoduo Pharmaceutical
  • Harbin Pharm. Group Sanjing Pharmaceutical
  • Hubei Weishi
  • China Res Double-Crane
  • Pfizer
  • Jilin Jinsheng Pharmaceutical
  • Jiangsu Langou Drug
  • Jiangsu Ruinian Qianjin Pharmacy
  • Zydus Pharmaceuticals
  • Shanghai Harvest Pharmaceutical
  • Shiyao YINHU Pharmaceutical
  • Chia Tai-Tianqing Pharmaceutical
  • Chongqing Yaoyou Pharmacy

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Verapamil Hydrochloride Injection Market Size (2021-2032)
  4. 2.2.2 Global Verapamil Hydrochloride Injection Sales (2021-2032)
  5. 2.2.3 Global Verapamil Hydrochloride Injection Market Average Price (2021-2032)
  6. 2.3 Verapamil Hydrochloride Injection by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Oral
  9. 2.3.3 Intravenous Injection
  10. 2.4 Verapamil Hydrochloride Injection by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital
  13. 2.4.3 Clinics
  14. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Verapamil Hydrochloride Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Verapamil Hydrochloride Injection Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Verapamil Hydrochloride Injection Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Verapamil Hydrochloride Injection Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Verapamil Hydrochloride Injection Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Verapamil Hydrochloride Injection, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Verapamil Hydrochloride Injection, Product Type & Application
  8. 3.8 Global Manufacturers of Verapamil Hydrochloride Injection, Established Date
  9. 3.9 Global Verapamil Hydrochloride Injection Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 ACIC Pharmaceuticals
  2. 4.1.1 ACIC Pharmaceuticals Company Information
  3. 4.1.2 ACIC Pharmaceuticals Business Overview
  4. 4.1.3 ACIC Pharmaceuticals Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 ACIC Pharmaceuticals Verapamil Hydrochloride Injection Product Portfolio
  6. 4.1.5 ACIC Pharmaceuticals Recent Developments
  7. 4.2 Exela Pharma
  8. 4.2.1 Exela Pharma Company Information
  9. 4.2.2 Exela Pharma Business Overview
  10. 4.2.3 Exela Pharma Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Exela Pharma Verapamil Hydrochloride Injection Product Portfolio
  12. 4.2.5 Exela Pharma Recent Developments
  13. 4.3 Gland Pharma
  14. 4.3.1 Gland Pharma Company Information
  15. 4.3.2 Gland Pharma Business Overview
  16. 4.3.3 Gland Pharma Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Gland Pharma Verapamil Hydrochloride Injection Product Portfolio
  18. 4.3.5 Gland Pharma Recent Developments
  19. 4.4 Mankind Pharma
  20. 4.4.1 Mankind Pharma Company Information
  21. 4.4.2 Mankind Pharma Business Overview
  22. 4.4.3 Mankind Pharma Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Mankind Pharma Verapamil Hydrochloride Injection Product Portfolio
  24. 4.4.5 Mankind Pharma Recent Developments
  25. 4.5 Duoduo Pharmaceutical
  26. 4.5.1 Duoduo Pharmaceutical Company Information
  27. 4.5.2 Duoduo Pharmaceutical Business Overview
  28. 4.5.3 Duoduo Pharmaceutical Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Duoduo Pharmaceutical Verapamil Hydrochloride Injection Product Portfolio
  30. 4.5.5 Duoduo Pharmaceutical Recent Developments
  31. 4.6 Harbin Pharm. Group Sanjing Pharmaceutical
  32. 4.6.1 Harbin Pharm. Group Sanjing Pharmaceutical Company Information
  33. 4.6.2 Harbin Pharm. Group Sanjing Pharmaceutical Business Overview
  34. 4.6.3 Harbin Pharm. Group Sanjing Pharmaceutical Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Harbin Pharm. Group Sanjing Pharmaceutical Verapamil Hydrochloride Injection Product Portfolio
  36. 4.6.5 Harbin Pharm. Group Sanjing Pharmaceutical Recent Developments
  37. 4.7 Hubei Weishi
  38. 4.7.1 Hubei Weishi Company Information
  39. 4.7.2 Hubei Weishi Business Overview
  40. 4.7.3 Hubei Weishi Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Hubei Weishi Verapamil Hydrochloride Injection Product Portfolio
  42. 4.7.5 Hubei Weishi Recent Developments
  43. 4.8 China Res Double-Crane
  44. 4.8.1 China Res Double-Crane Company Information
  45. 4.8.2 China Res Double-Crane Business Overview
  46. 4.8.3 China Res Double-Crane Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 China Res Double-Crane Verapamil Hydrochloride Injection Product Portfolio
  48. 4.8.5 China Res Double-Crane Recent Developments
  49. 4.9 Pfizer
  50. 4.9.1 Pfizer Company Information
  51. 4.9.2 Pfizer Business Overview
  52. 4.9.3 Pfizer Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Pfizer Verapamil Hydrochloride Injection Product Portfolio
  54. 4.9.5 Pfizer Recent Developments
  55. 4.10 Jilin Jinsheng Pharmaceutical
  56. 4.10.1 Jilin Jinsheng Pharmaceutical Company Information
  57. 4.10.2 Jilin Jinsheng Pharmaceutical Business Overview
  58. 4.10.3 Jilin Jinsheng Pharmaceutical Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Jilin Jinsheng Pharmaceutical Verapamil Hydrochloride Injection Product Portfolio
  60. 4.10.5 Jilin Jinsheng Pharmaceutical Recent Developments
  61. 4.11 Jiangsu Langou Drug
  62. 4.11.1 Jiangsu Langou Drug Company Information
  63. 4.11.2 Jiangsu Langou Drug Business Overview
  64. 4.11.3 Jiangsu Langou Drug Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Jiangsu Langou Drug Verapamil Hydrochloride Injection Product Portfolio
  66. 4.11.5 Jiangsu Langou Drug Recent Developments
  67. 4.12 Jiangsu Ruinian Qianjin Pharmacy
  68. 4.12.1 Jiangsu Ruinian Qianjin Pharmacy Company Information
  69. 4.12.2 Jiangsu Ruinian Qianjin Pharmacy Business Overview
  70. 4.12.3 Jiangsu Ruinian Qianjin Pharmacy Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Jiangsu Ruinian Qianjin Pharmacy Verapamil Hydrochloride Injection Product Portfolio
  72. 4.12.5 Jiangsu Ruinian Qianjin Pharmacy Recent Developments
  73. 4.13 Zydus Pharmaceuticals
  74. 4.13.1 Zydus Pharmaceuticals Company Information
  75. 4.13.2 Zydus Pharmaceuticals Business Overview
  76. 4.13.3 Zydus Pharmaceuticals Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Zydus Pharmaceuticals Verapamil Hydrochloride Injection Product Portfolio
  78. 4.13.5 Zydus Pharmaceuticals Recent Developments
  79. 4.14 Shanghai Harvest Pharmaceutical
  80. 4.14.1 Shanghai Harvest Pharmaceutical Company Information
  81. 4.14.2 Shanghai Harvest Pharmaceutical Business Overview
  82. 4.14.3 Shanghai Harvest Pharmaceutical Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Shanghai Harvest Pharmaceutical Verapamil Hydrochloride Injection Product Portfolio
  84. 4.14.5 Shanghai Harvest Pharmaceutical Recent Developments
  85. 4.15 Shiyao YINHU Pharmaceutical
  86. 4.15.1 Shiyao YINHU Pharmaceutical Company Information
  87. 4.15.2 Shiyao YINHU Pharmaceutical Business Overview
  88. 4.15.3 Shiyao YINHU Pharmaceutical Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Shiyao YINHU Pharmaceutical Verapamil Hydrochloride Injection Product Portfolio
  90. 4.15.5 Shiyao YINHU Pharmaceutical Recent Developments
  91. 4.16 Chia Tai-Tianqing Pharmaceutical
  92. 4.16.1 Chia Tai-Tianqing Pharmaceutical Company Information
  93. 4.16.2 Chia Tai-Tianqing Pharmaceutical Business Overview
  94. 4.16.3 Chia Tai-Tianqing Pharmaceutical Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Chia Tai-Tianqing Pharmaceutical Verapamil Hydrochloride Injection Product Portfolio
  96. 4.16.5 Chia Tai-Tianqing Pharmaceutical Recent Developments
  97. 4.17 Chongqing Yaoyou Pharmacy
  98. 4.17.1 Chongqing Yaoyou Pharmacy Company Information
  99. 4.17.2 Chongqing Yaoyou Pharmacy Business Overview
  100. 4.17.3 Chongqing Yaoyou Pharmacy Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Chongqing Yaoyou Pharmacy Verapamil Hydrochloride Injection Product Portfolio
  102. 4.17.5 Chongqing Yaoyou Pharmacy Recent Developments
5 Global Verapamil Hydrochloride Injection Market Scenario by Region
  1. 5.1 Global Verapamil Hydrochloride Injection Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Verapamil Hydrochloride Injection Sales by Region: 2021-2032
  3. 5.2.1 Global Verapamil Hydrochloride Injection Sales by Region: 2021-2026
  4. 5.2.2 Global Verapamil Hydrochloride Injection Sales by Region: 2027-2032
  5. 5.3 Global Verapamil Hydrochloride Injection Revenue by Region: 2021-2032
  6. 5.3.1 Global Verapamil Hydrochloride Injection Revenue by Region: 2021-2026
  7. 5.3.2 Global Verapamil Hydrochloride Injection Revenue by Region: 2027-2032
  8. 5.4 North America Verapamil Hydrochloride Injection Market Facts & Figures by Country
  9. 5.4.1 North America Verapamil Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Verapamil Hydrochloride Injection Sales by Country (2021-2032)
  11. 5.4.3 North America Verapamil Hydrochloride Injection Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Verapamil Hydrochloride Injection Market Facts & Figures by Country
  16. 5.5.1 Europe Verapamil Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Verapamil Hydrochloride Injection Sales by Country (2021-2032)
  18. 5.5.3 Europe Verapamil Hydrochloride Injection Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Verapamil Hydrochloride Injection Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Verapamil Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Verapamil Hydrochloride Injection Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Verapamil Hydrochloride Injection Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Verapamil Hydrochloride Injection Market Facts & Figures by Country
  41. 5.7.1 South America Verapamil Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Verapamil Hydrochloride Injection Sales by Country (2021-2032)
  43. 5.7.3 South America Verapamil Hydrochloride Injection Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Verapamil Hydrochloride Injection Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Verapamil Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Verapamil Hydrochloride Injection Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Verapamil Hydrochloride Injection Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Verapamil Hydrochloride Injection Sales by Type (2021-2032)
  2. 6.1.1 Global Verapamil Hydrochloride Injection Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Verapamil Hydrochloride Injection Sales Market Share by Type (2021-2032)
  4. 6.2 Global Verapamil Hydrochloride Injection Revenue by Type (2021-2032)
  5. 6.2.1 Global Verapamil Hydrochloride Injection Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Verapamil Hydrochloride Injection Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Verapamil Hydrochloride Injection Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Verapamil Hydrochloride Injection Sales by Application (2021-2032)
  2. 7.1.1 Global Verapamil Hydrochloride Injection Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Verapamil Hydrochloride Injection Sales Market Share by Application (2021-2032)
  4. 7.2 Global Verapamil Hydrochloride Injection Revenue by Application (2021-2032)
  5. 7.2.1 Global Verapamil Hydrochloride Injection Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Verapamil Hydrochloride Injection Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Verapamil Hydrochloride Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Verapamil Hydrochloride Injection Value Chain Analysis
  2. 8.1.1 Verapamil Hydrochloride Injection Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Verapamil Hydrochloride Injection Production Mode & Process
  5. 8.2 Verapamil Hydrochloride Injection Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Verapamil Hydrochloride Injection Distributors
  8. 8.2.3 Verapamil Hydrochloride Injection Customers
9 Global Verapamil Hydrochloride Injection Analyzing Market Dynamics
  1. 9.1 Verapamil Hydrochloride Injection Industry Trends
  2. 9.2 Verapamil Hydrochloride Injection Industry Drivers
  3. 9.3 Verapamil Hydrochloride Injection Industry Opportunities and Challenges
  4. 9.4 Verapamil Hydrochloride Injection Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst